======= TXNDC17 =======
== Gene Information ==
* **Official Symbol**: TXNDC17
* **Official Name**: thioredoxin domain containing 17
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84817|84817]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BRA2|Q9BRA2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TXNDC17&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TXNDC17|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616967|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Disulfide reductase. May participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions. Modulates TNF-alpha signaling and NF-kappa-B activation. Has peroxidase activity and may contribute to the elimination of cellular hydrogen peroxide. {ECO:0000269|PubMed:14607843, ECO:0000269|PubMed:14607844}.
|DUF953|
|protein-disulfide reductase activity|
|peroxidase activity|
|cellular oxidant detoxification|
|cellular detoxification|
|tumor necrosis factor-mediated signaling pathway|
|detoxification|
|cellular response to toxic substance|
|cellular response to tumor necrosis factor|
|response to tumor necrosis factor|
|response to toxic substance|
|cytokine-mediated signaling pathway|
|oxidation-reduction process|
|cellular response to cytokine stimulus|
|response to cytokine|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.38|
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|1.73|
|[[:results:exp507|Monensin 0.3μM R08 exp507]]|1.73|
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|1.77|
|[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|1.95|
|[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.18|
|[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|2.27|
|[[:results:exp22|MLN-4924 2μM R00 exp22]]|2.34|
|[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.37|
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|2.89|
^Gene^Correlation^
|[[:human genes:h:hars|HARS]]|0.442|
|[[:human genes:w:wdr24|WDR24]]|0.405|
Global Fraction of Cell Lines Where Essential: 2/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|1/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5494
* **Expression level (log2 read counts)**: 4.73
{{:chemogenomics:nalm6 dist.png?nolink |}}